16 Apr 2021 The Biden-Harris administration’s Department of Health and Human Services (HHS) announced it is reversing the Trump administration’s decision to end taxpayer funding for experimental research that uses fetal tissue derived from aborted babies. The National Institutes of Health (NIH), an agency under the authority of HHS, announced Friday an “Update on Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research”: On June 5, 2019, HHS announced that NIH intramural research that requires new acquisition of human fetal tissue from elective abortions will not be conducted. Simultaneously, HHS announced new requirements for documentation and review by an Ethics Advisory Board of extramural research applications for NIH grants, cooperative agreements, and R&D contracts proposing the use of human fetal tissue obtained from elective abortions.